Schwab Andrew J.insider trades
In SEC Form 4 filings, Schwab Andrew J. is listed as Director, 10% owner of Skye Bioscience, Inc. (SKYE) and Director of Camp4 Therapeutics Corp (CAMP). In the last 90 days, Schwab Andrew J. sold $2.80M across 2 companies on the open market and bought none.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-21
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| SKYESkye Bioscience, Inc. | Sep 23 | Sep 24 | S | 114,851 | $1.61 | Sale −$184,910 | not reported | No | Form 4 |
| SKYESkye Bioscience, Inc. | Sep 23 | Sep 24 | S | 4,528 | $1.61 | Sale −$7,290 | not reported | No | Form 4 |
| SKYESkye Bioscience, Inc. | Sep 22 | Sep 24 | S | 27,612 | $1.65 | Sale −$45,560 | 114,851 | No | Form 4 |
| SKYESkye Bioscience, Inc. | Sep 22 | Sep 24 | S | 1,088 | $1.65 | Sale −$1,795 | 4,528 | No | Form 4 |
| SKYESkye Bioscience, Inc. | Sep 16 | Sep 18 | S | 32,607 | $1.91 | Sale −$62,279 | 142,463 | No | Form 4 |
| SKYESkye Bioscience, Inc. | Sep 16 | Sep 18 | S | 1,285 | $1.91 | Sale −$2,454 | 5,616 | No | Form 4 |
| CAMPCamp4 Therapeutics Corp | Aug 27 | Aug 31 | S | 400,000 | $4.04 | Sale −$1,616,000 | 2,033,270 | No | Form 4 |
| CAMPCamp4 Therapeutics Corp | Aug 24 | Aug 26 | S | 10 | $4.50 | Sale −$45 | 2,433,270 | No | Form 4 |
| CAMPCamp4 Therapeutics Corp | Aug 21 | Aug 21 | S | 32,018 | $4.50 | Sale −$144,081 | 2,433,280 | No | Form 4 |
| CAMPCamp4 Therapeutics Corp | Aug 20 | Aug 21 | S | 114,700 | $4.54 | Sale −$520,738 | 2,465,298 | No | Form 4 |
| CAMPCamp4 Therapeutics Corp | Aug 19 | Aug 21 | S | 45,147 | $4.76 | Sale −$214,900 | 2,579,998 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.